All In Biotech

Free tool

FAERS Monitor: Axtle

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 210661 or its brand name (Axtle, Pemetrexed Dipotassium). Reports on generic versions are filed under their own applications.

Reports

22,302

Serious

21,858

98% of reports

Hospitalization

10,318

Death reported

3,873

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • malignant neoplasm progression1,726
  • anaemia1,313
  • disease progression1,147
  • off label use1,130
  • nausea1,071
  • neutropenia1,071
  • diarrhoea1,041
  • pancytopenia1,010
  • thrombocytopenia997
  • drug ineffective983
  • acute kidney injury840
  • vomiting823
  • pneumonia800
  • febrile neutropenia799
  • death797

Reports by year received

View as table
YearReports
200436
200542
200617
200783
2008123
2009300
2010482
2011492
2012323
2013240
2014294
2015293
2016489
2017546
2018839
2019851
20201,050
20211,534
20222,216
20232,700
20243,449
20253,227
20262,676

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,031,857 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pancytopeniaSignal1,01017.316.315,295
malignant neoplasm progressionSignal1,72616.115.424,220
febrile neutropeniaSignal79911.510.77,570
disease progressionSignal1,1479.28.78,365
thrombocytopeniaSignal9978.58.06,542
neutropeniaSignal1,0717.57.15,997
anaemiaSignal1,3136.56.26,158
acute kidney injurySignal8405.24.92,850
pneumoniaSignal8002.32.2616
vomiting8231.71.5216
diarrhoea1,0411.51.4191
nausea1,0711.31.266
off label use1,1301.21.245
death7970.90.815
drug ineffective9830.70.7131

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.